The main reasons for not using an angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) were HF with a preserved ejection fraction, acute kidney injury, and chronic renal failure. Here, ACE is linked to hydrops fetalis.